Resmed Inc (RMD) Monthly Backtest Results
Backtest Summary
This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.
| Entry Date | Exit Date | Profit or Loss | CAGR |
|---|---|---|---|
| 01 October 2025 | 03 November 2025 | -8.94% | -65.62% |
| 02 June 2025 | 03 November 2025 | 1.78% | 4.3% |
| 01 May 2024 | 01 April 2025 | 4.09% | 4.47% |
| 01 July 2021 | 01 February 2022 | -6.18% | -10.3% |
| 01 July 2019 | 03 May 2021 | 57.65% | 28.05% |
| 03 January 2017 | 01 February 2019 | 57.22% | 24.31% |
| 01 July 2016 | 01 November 2016 | -6.43% | -18.02% |
| 01 April 2016 | 02 May 2016 | -4.03% | -38.37% |
| Total Return | 95.17% | ||
The monthly data for Resmed Inc (exchange: XNYS symbol: RMD) was last updated 27 Dec 2025 06:41. Data for this stock is available from 04 Jan 2016 - 26 Dec 2025.
